CredoScientia - Bibliothèque

Development of conversion therapy for advanced hepatocellular carcinoma.

Thérapies de Conversion

Matsuki, R., Kogure, M., Hasui, N., Momose, H., Suzuki, Y., & Sakamoto, Y. (2023). Development of conversion therapy for advanced hepatocellular carcinoma.. Hepatobiliary Surg Nutr, 12(3), 453-456. https://doi.org/10.21037/hbsn-23-204

01/06/2023 Lire →

Gender Identity Change Efforts Are Associated with Depression, Panic Disorder, and Suicide Attempts in South Korean Transgender Adults.

PURPOSE: Gender identity change efforts (GICEs), sometimes referred to as "conversion therapy," are considered pseudoscientific and unethical practices that are not supported by the existing scientifi…

Thérapies de Conversion

Lee, H., Operario, D., Restar, A. J., Choo, S., Kim, R., Eom, Y. J., Yi, H., & Kim, S. S. (2023). Gender Identity Change Efforts Are Associated with Depression, Panic Disorder, and Suicide Attempts in South Korean Transgender Adults.. Transgend Health, 8(3), 273-281. https://doi.org/10.1089/trgh.2021.0171

01/06/2023 Lire →

Conversion therapy for massive hepatocellular carcinoma: A case report and literature review.

KEY CLINICAL MESSAGE: For potentially resectable HCC, a more aggressive conversion therapy strategy (high-intensity combined with multiple treatment modalities) can be used.ABSTRACT: Hepatocellular ca…

Thérapies de Conversion

Zhou, Z., Xu, X., Sun, M., Liu, Y., Liu, Q., Chen, C., & Yin, Y. (2023). Conversion therapy for massive hepatocellular carcinoma: A case report and literature review.. Clin Case Rep, 11(6), e7533. https://doi.org/10.1002/ccr3.7533

01/06/2023 Lire →

The impact of curative conversion therapy aimed at a cancer-free state in patients with hepatocellular carcinoma treated with atezolizumab plus bevacizumab.

BACKGROUND AND AIMS: We aimed to validate the predictive factors for tumor response and the prognostic impact of conversion therapy aimed at cancer- and drug-free states in patients with unresectable …

Thérapies de Conversion

Shimose, S., Iwamoto, H., Shirono, T., Tanaka, M., Niizeki, T., Kajiwara, M., Itano, S., Yano, Y., Matsugaki, S., Moriyama, E., Noda, Y., Nakano, M., Kuromatsu, R., Koga, H., & Kawaguchi, T. (2023). The impact of curative conversion therapy aimed at a cancer-free state in patients with hepatocellular carcinoma treated with atezolizumab plus bevacizumab.. Cancer Med, 12(11), 12325-12335. https://doi.org/10.1002/cam4.5931

01/06/2023 Lire →

Comparison of the efficacy between immunochemotherapy and chemotherapy in gastric cancer accompanied with synchronous liver metastases: A real-world retrospective study.

BACKGROUND: Few studies have investigated the efficacy of comprehensive therapies, including immunotherapy, for gastric cancer with synchronous liver metastases (GCLM). We retrospectively compared the…

Thérapies de Conversion

Lin, G. T., Liu, Z. Y., Shang-Guan, Z. X., Zeng, G. R., Lin, J. X., Wu, J., Chen, Q. Y., Xie, J. W., Li, P., Huang, C. M., & Zheng, C. H. (2023). Comparison of the efficacy between immunochemotherapy and chemotherapy in gastric cancer accompanied with synchronous liver metastases: A real-world retrospective study.. Cancer Med, 12(11), 12221-12233. https://doi.org/10.1002/cam4.5917

01/06/2023 Lire →

Inflammation-related nomogram for predicting survival of patients with unresectable hepatocellular carcinoma received conversion therapy.

BACKGROUND: The efficacy of conversion therapy for patients with unresectable hepatocellular carcinoma (HCC) is a common clinical concern.AIM: To analyse the prognostic factors of overall survival (OS…

Thérapies de Conversion

Wu, J. L., Luo, J. Y., Jiang, Z. B., Huang, S. B., Chen, G. R., Ran, H. Y., Liang, Q. Y., Huang, M. S., Lai, L. S., & Chen, J. W. (2023). Inflammation-related nomogram for predicting survival of patients with unresectable hepatocellular carcinoma received conversion therapy.. World J Gastroenterol, 29(20), 3168-3184. https://doi.org/10.3748/wjg.v29.i20.3168

28/05/2023 Lire →

[Recent progress and future prospects of treatment for peritoneal metastasis in gastric cancer].

Peritoneal metastasis is one of the most frequent patterns of metastasis in gastric cancer, and remains a major unmet clinical problem. Thus, systemic chemotherapy remains the mainstay of treatment fo…

Thérapies de Conversion

Xu, Y., & Wang, Z. N. (2023). [Recent progress and future prospects of treatment for peritoneal metastasis in gastric cancer].. Zhonghua Wei Chang Wai Ke Za Zhi, 26(5), 414-418. https://doi.org/10.3760/cma.j.cn441530-20230301-00059

25/05/2023 Lire →

Real-world practice of conversion surgery for unresectable hepatocellular carcinoma - a single center data of 26 consecutive patients.

AIM: To understand the proportion of uHCC (unresectable hepatocellular carcinoma) patients who achieve successful conversion resection in a high-volume setting with state of the art treatment options.…

Thérapies de Conversion

Zhang, B., Shi, X., Cui, K., Li, Z., Li, L., Liu, Z., Zhang, C., Sun, P., Zhong, J., Sun, Z., Chang, Z., Ma, Z., Gordon-Weeks, A., Li, M., & Zhao, L. (2023). Real-world practice of conversion surgery for unresectable hepatocellular carcinoma - a single center data of 26 consecutive patients.. BMC Cancer, 23(1), 465. https://doi.org/10.1186/s12885-023-10955-7

20/05/2023 Lire →

Radiographic and α-fetoprotein response predict pathologic complete response to immunotherapy plus a TKI in hepatocellular carcinoma: a multicenter study.

BACKGROUND: Pathologic complete response (pCR) following preoperative systemic therapy is associated with improved outcomes after subsequent liver transplant/resection in hepatocellular carcinoma (HCC…

Thérapies de Conversion

Huang, C., Zhu, X. D., Shen, Y. H., Xu, B., Wu, D., Ji, Y., Chen, L. L., Song, T. Q., Zhang, W., Zeng, Z. M., Huang, H. S., Wang, K., Huang, L. Q., Chen, Y. J., Yang, Y. C., Zhou, L. D., Long, G., Zhao, H. T., Wang, Y. C., … Sun, H. C. (2023). Radiographic and α-fetoprotein response predict pathologic complete response to immunotherapy plus a TKI in hepatocellular carcinoma: a multicenter study.. BMC Cancer, 23(1), 416. https://doi.org/10.1186/s12885-023-10898-z

09/05/2023 Lire →

The Effectiveness of the Combination of Arterial Infusion Chemotherapy and Radiotherapy for Biliary Tract Cancer: A Prospective Pilot Study.

The standard treatment of unresectable biliary tract cancer (BTC) has shown an insufficient response rate (RR). Our retrospective setting revealed that a combination therapy consisting of intra-arteri…

Thérapies de Conversion

Goto, T., Sato, H., Fujibayashi, S., Okada, T., Hayashi, A., Kawabata, H., Yuzawa, S., Ishitoya, S., Yamashina, M., & Fujiya, M. (2023). The Effectiveness of the Combination of Arterial Infusion Chemotherapy and Radiotherapy for Biliary Tract Cancer: A Prospective Pilot Study.. Cancers (Basel), 15(9). https://doi.org/10.3390/cancers15092616

05/05/2023 Lire →

Survival of Patients With Metastatic Rectum Cancer Who Underwent Metastasectomy Following Conversion Chemotherapy Sans Pelvic Radiotherapy: A Turkish Oncology Group Study.

BACKGROUND: The management of early rectal cancer is different from that of colon cancer in terms of radiotherapy (RT) requirements or neoadjuvant treatment. It is not clear how the course of rectal c…

Thérapies de Conversion

Almuradova, E., Yalcin, S., Arıkan, R., Ayhan, M., Demir, H., Cevik, G. T., Karaca, M., Petekkaya, I., & Karabulut, B. (2023). Survival of Patients With Metastatic Rectum Cancer Who Underwent Metastasectomy Following Conversion Chemotherapy Sans Pelvic Radiotherapy: A Turkish Oncology Group Study.. Cureus, 15(5), e39119. https://doi.org/10.7759/cureus.39119

01/05/2023 Lire →

Conversion therapy, suicidality, and running away: An analysis of transgender youth in the U.S.

This study analyzes the relationship between conversion therapy and mental health and wellbeing of transgender youth in the U.S. We create a retrospective panel of transgender youth using the 2015 U.S…

Thérapies de Conversion

Campbell, T., & Rodgers, Y. V. M. (2023). Conversion therapy, suicidality, and running away: An analysis of transgender youth in the U.S.. J Health Econ, 89, 102750. https://doi.org/10.1016/j.jhealeco.2023.102750

01/05/2023 Lire →